Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 151

1.

Limits on Anisotropy in the Nanohertz Stochastic Gravitational Wave Background.

Taylor SR, Mingarelli CM, Gair JR, Sesana A, Theureau G, Babak S, Bassa CG, Brem P, Burgay M, Caballero RN, Champion DJ, Cognard I, Desvignes G, Guillemot L, Hessels JW, Janssen GH, Karuppusamy R, Kramer M, Lassus A, Lazarus P, Lentati L, Liu K, Osłowski S, Perrodin D, Petiteau A, Possenti A, Purver MB, Rosado PA, Sanidas SA, Smits R, Stappers B, Tiburzi C, van Haasteren R, Vecchio A, Verbiest JP; EPTA Collaboration.

Phys Rev Lett. 2015 Jul 24;115(4):041101. Epub 2015 Jul 22.

PMID:
26252674
2.

Living on the edge: transfer and traffic of E. coli in a confined flow.

Figueroa-Morales N, Leonardo Miño G, Rivera A, Caballero R, Clément E, Altshuler E, Lindner A.

Soft Matter. 2015 Jul 29;11(31):6284-93. doi: 10.1039/c5sm00939a.

PMID:
26161542
3.

Assessment of wastewater treatment alternatives for small communities: An analytic network process approach.

Molinos-Senante M, Gómez T, Caballero R, Hernández-Sancho F, Sala-Garrido R.

Sci Total Environ. 2015 Nov 1;532:676-87. doi: 10.1016/j.scitotenv.2015.06.059. Epub 2015 Jun 25.

PMID:
26119382
4.

Concordance Between BeamF3 and MRI-neuronavigated Target Sites for Repetitive Transcranial Magnetic Stimulation of the Left Dorsolateral Prefrontal Cortex.

Mir-Moghtadaei A, Caballero R, Fried P, Fox MD, Lee K, Giacobbe P, Daskalakis ZJ, Blumberger DM, Downar J.

Brain Stimul. 2015 May 29. pii: S1935-861X(15)00962-6. doi: 10.1016/j.brs.2015.05.008. [Epub ahead of print]

5.

Defining breast cancer intrinsic subtypes by quantitative receptor expression.

Cheang MC, Martin M, Nielsen TO, Prat A, Voduc D, Rodriguez-Lescure A, Ruiz A, Chia S, Shepherd L, Ruiz-Borrego M, Calvo L, Alba E, Carrasco E, Caballero R, Tu D, Pritchard KI, Levine MN, Bramwell VH, Parker J, Bernard PS, Ellis MJ, Perou CM, Di Leo A, Carey LA.

Oncologist. 2015 May;20(5):474-82. doi: 10.1634/theoncologist.2014-0372. Epub 2015 Apr 23.

PMID:
25908555
6.

Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor positive, human epidermal growth factor receptor negative, node negative early-stage breast cancer.

Martín M, González-Rivera M, Morales S, de la Haba-Rodriguez J, González-Cortijo L, Manso L, Albanell J, González-Martín A, González S, Arcusa A, de la Cruz-Merino L, Rojo F, Vidal M, Galván P, Aguirre E, Morales C, Ferree S, Pompilio K, Casas M, Caballero R, Goicoechea U, Carrasco E, Michalopoulos S, Hornberger J, Prat A.

Curr Med Res Opin. 2015 Jun;31(6):1129-37. doi: 10.1185/03007995.2015.1037730. Epub 2015 Apr 23.

PMID:
25851308
7.

Role of the bridge in photoinduced electron transfer in porphyrin-fullerene dyads.

Pelado B, Abou-Chahine F, Calbo J, Caballero R, de la Cruz P, Junquera-Hernández JM, Ortí E, Tkachenko NV, Langa F.

Chemistry. 2015 Apr 7;21(15):5814-25. doi: 10.1002/chem.201406514. Epub 2015 Mar 3.

PMID:
25737468
8.

Duration of anticoagulation after venous thromboembolism in real world clinical practice.

Ageno W, Samperiz A, Caballero R, Dentali F, Di Micco P, Prandoni P, Becattini C, Uresandi F, Verhamme P, Monreal M; RIETE investigators.

Thromb Res. 2015 Apr;135(4):666-72. doi: 10.1016/j.thromres.2015.02.001. Epub 2015 Feb 7.

PMID:
25708926
9.

Regulation of SCN5A by microRNAs: miR-219 modulates SCN5A transcript expression and the effects of flecainide intoxication in mice.

Daimi H, Lozano-Velasco E, Haj Khelil A, Chibani JB, Barana A, Amorós I, González de la Fuente M, Caballero R, Aranega A, Franco D.

Heart Rhythm. 2015 Jun;12(6):1333-42. doi: 10.1016/j.hrthm.2015.02.018. Epub 2015 Feb 19.

PMID:
25701775
10.

Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM/2009-05): a randomized, noninferiority phase II trial with a pharmacogenetic analysis.

Martín M, Martínez N, Ramos M, Calvo L, Lluch A, Zamora P, Muñoz M, Carrasco E, Caballero R, García-Sáenz JÁ, Guerra E, Caronia D, Casado A, Ruíz-Borrego M, Hernando B, Chacón JI, De la Torre-Montero JC, Jimeno MÁ, Heras L, Alonso R, De la Haba J, Pita G, Constenla M, González-Neira A.

Oncologist. 2015 Feb;20(2):111-2. doi: 10.1634/theoncologist.2014-0379. Epub 2015 Jan 19.

11.

Cancer chemotherapy and cardiac arrhythmias: a review.

Tamargo J, Caballero R, Delpón E.

Drug Saf. 2015 Feb;38(2):129-52. doi: 10.1007/s40264-014-0258-4.

PMID:
25577497
12.
13.

Structural basis of drugs that increase cardiac inward rectifier Kir2.1 currents.

Gómez R, Caballero R, Barana A, Amorós I, De Palm SH, Matamoros M, Núñez M, Pérez-Hernández M, Iriepa I, Tamargo J, Delpón E.

Cardiovasc Res. 2014 Nov 1;104(2):337-46. doi: 10.1093/cvr/cvu203. Epub 2014 Sep 9.

PMID:
25205296
14.

Assessing the sustainability of small wastewater treatment systems: a composite indicator approach.

Molinos-Senante M, Gómez T, Garrido-Baserba M, Caballero R, Sala-Garrido R.

Sci Total Environ. 2014 Nov 1;497-498:607-17. doi: 10.1016/j.scitotenv.2014.08.026. Epub 2014 Aug 27.

PMID:
25169875
15.

Chronic atrial fibrillation increases microRNA-21 in human atrial myocytes decreasing L-type calcium current.

Barana A, Matamoros M, Dolz-Gaitón P, Pérez-Hernández M, Amorós I, Núñez M, Sacristán S, Pedraz Á, Pinto Á, Fernández-Avilés F, Tamargo J, Delpón E, Caballero R.

Circ Arrhythm Electrophysiol. 2014 Oct;7(5):861-8. doi: 10.1161/CIRCEP.114.001709. Epub 2014 Aug 8.

PMID:
25107449
16.

Predicting response and survival in chemotherapy-treated triple-negative breast cancer.

Prat A, Lluch A, Albanell J, Barry WT, Fan C, Chacón JI, Parker JS, Calvo L, Plazaola A, Arcusa A, Seguí-Palmer MA, Burgues O, Ribelles N, Rodriguez-Lescure A, Guerrero A, Ruiz-Borrego M, Munarriz B, López JA, Adamo B, Cheang MC, Li Y, Hu Z, Gulley ML, Vidal MJ, Pitcher BN, Liu MC, Citron ML, Ellis MJ, Mardis E, Vickery T, Hudis CA, Winer EP, Carey LA, Caballero R, Carrasco E, Martín M, Perou CM, Alba E.

Br J Cancer. 2014 Oct 14;111(8):1532-41. doi: 10.1038/bjc.2014.444. Epub 2014 Aug 7.

17.

Improving short term instability for quantitative analyses with portable electronic noses.

Macías MM, Agudo JE, Manso AG, Orellana CJ, Velasco HM, Caballero RG.

Sensors (Basel). 2014 Jun 13;14(6):10514-26. doi: 10.3390/s140610514.

18.

Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial.

Martin M, Brase JC, Calvo L, Krappmann K, Ruiz-Borrego M, Fisch K, Ruiz A, Weber KE, Munarriz B, Petry C, Rodriguez CA, Kronenwett R, Crespo C, Alba E, Carrasco E, Casas M, Caballero R, Rodriguez-Lescure A.

Breast Cancer Res. 2014 Apr 12;16(2):R38. doi: 10.1186/bcr3642.

19.

Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial.

Alba E, Albanell J, de la Haba J, Barnadas A, Calvo L, Sánchez-Rovira P, Ramos M, Rojo F, Burgués O, Carrasco E, Caballero R, Porras I, Tibau A, Cámara MC, Lluch A.

Br J Cancer. 2014 Mar 4;110(5):1139-47. doi: 10.1038/bjc.2013.831. Epub 2014 Jan 23.

20.

Functional characterization of a novel frameshift mutation in the C-terminus of the Nav1.5 channel underlying a Brugada syndrome with variable expression in a Spanish family.

Dolz-Gaitón P, Núñez M, Núñez L, Barana A, Amorós I, Matamoros M, Pérez-Hernández M, González de la Fuente M, Alvarez-López M, Macías-Ruiz R, Tercedor-Sánchez L, Jiménez-Jáimez J, Delpón E, Caballero R, Tamargo J.

PLoS One. 2013 Nov 25;8(11):e81493. doi: 10.1371/journal.pone.0081493. eCollection 2013.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk